Health

Create a Massachusetts Cancer Mission connecting Dana-Farber, Mass General Brigham, UMass Chan, Boston Medical Center, community providers, universities, Moderna, and other biotech companies willing to participate. Set shared research priorities and publish who has actually committed.

Support complementary approaches: personalized immunotherapies, vaccines, cell therapies, targeted medicines, diagnostics, and fundamental research. Fund competitive programs with independent scientific review, clear milestones, and patient representation. No single company or technology can carry the whole mission.

Build a statewide trial-navigation network, common administrative tools, coordinated review where appropriate, and community research sites. Help patients and clinicians find suitable studies and remove practical barriers such as travel, time off work, and language.

Speed the administration of research while maintaining informed consent, ethical review, and applicable FDA requirements. Invest in trial manufacturing and trained staff so promising discoveries can be tested rigorously. Measure enrollment, representativeness, startup time, and clinically meaningful outcomes.

Connect primary care, evidence-based screening, rapid diagnostic follow-up, and oncology treatment. Prioritize communities where access is weakest. Evaluate AI-assisted tools for a defined clinical use, with clinicians responsible for care and follow-up.

A risk prediction is not a diagnosis, and a screening test is useful only if the next step is available. Pair promising treatments with affordability, navigation, and delivery capacity. Measure whether patients get timely, appropriate care and live longer, not simply whether more tests are performed.